Daclahep 60mg Tablet

Description

Daclahep is not intended to be used as a stand-alone treatment. Daclatasvir is used in combination with other antiviral medicines, with the specific combination and treatment duration determined by the patient’s HCV genotype, liver condition, previous treatment history and current clinical guidelines.

What Is Daclahep 60mg?

Daclahep 60mg is an oral tablet containing daclatasvir, an HCV direct-acting antiviral.

Daclatasvir targets the hepatitis C virus protein NS5A, which is important for viral replication. By inhibiting NS5A, daclatasvir helps interfere with the HCV replication cycle.

Because hepatitis C treatment depends on several clinical factors, Daclahep should be used only as part of a treatment regimen prescribed by a qualified healthcare professional.

What Is Daclahep Used For?

Daclahep 60mg is used as part of antiviral therapy for chronic hepatitis C infection.

Hepatitis C is a viral infection that primarily affects the liver. If untreated, chronic HCV infection can potentially lead to progressive liver disease.

Daclatasvir-containing treatment regimens may be used for different HCV genotypes and patient populations depending on the approved treatment regimen in a particular country.

The Australian TGA has assessed and approved daclatasvir-containing products as prescription medicines, while product availability and approved indications can differ between countries.

How Does Daclatasvir Work?

Daclatasvir is a direct-acting antiviral (DAA) that targets the hepatitis C virus NS5A protein.

NS5A plays an important role in HCV replication and assembly. Blocking this protein interferes with the virus’s ability to reproduce.

Daclatasvir is therefore used as part of combination antiviral therapy rather than as a single-agent treatment.

Daclahep 60mg Key Information

Daclatasvir 60mg tablets contain daclatasvir dihydrochloride as the active pharmaceutical ingredient. Official Australian product information identifies daclatasvir as a selective inhibitor of the HCV NS5A replication complex.

Daclahep and Hepatitis C

Chronic hepatitis C (HCV) is a viral infection that can cause inflammation and progressive damage to the liver.

Modern hepatitis C treatment uses direct-acting antiviral medicines to target specific stages of the viral life cycle. Daclatasvir is one such antiviral and targets NS5A.

Successful antiviral treatment can result in clearance of HCV from the blood, but treatment selection should be individualized by a healthcare professional.

Daclatasvir With Other Antiviral Medicines

Daclahep 60mg should not be used alone for hepatitis C treatment.

Daclatasvir is prescribed with other antiviral medicines. Depending on the clinical situation and applicable treatment guidelines, combinations may include sofosbuvir and, in certain historical or specific regimens, other antiviral agents.

The appropriate combination depends on:

• HCV genotype
• Previous HCV treatment
• Liver function
• Presence or absence of cirrhosis
• Other medical conditions
• Other medicines being taken
• Local treatment guidelines

A healthcare professional should determine the appropriate HCV treatment regimen.

How to Take Daclahep 60mg

Take Daclahep exactly as prescribed by your hepatitis C specialist or healthcare professional.

Daclatasvir tablets can generally be taken with or without food, depending on the product information. The tablet should be swallowed whole with water.

Important points:

• Take the medicine at approximately the same time each day.
• Do not skip doses.
• Do not stop treatment without consulting your doctor.
• Do not change the dose yourself.
• Take Daclahep together with the other medicines included in your prescribed HCV regimen.

Consistent treatment is important for successful antiviral therapy.

Daclahep 60mg Dosage

The appropriate daclatasvir dosage and treatment duration depend on the specific HCV treatment regimen.

Although 60mg once daily is a commonly recognized daclatasvir dose, patients should follow the exact regimen prescribed by their healthcare professional.

Do not use a generic internet dosage schedule for hepatitis C treatment because treatment recommendations can vary according to genotype, cirrhosis status, previous treatment and other clinical factors.

Daclahep Side Effects

Like other medicines, daclatasvir-containing treatment can cause side effects.

Depending on the overall antiviral regimen, reported effects may include:

• Headache
• Fatigue
• Nausea
• Diarrhea
• Dizziness

Side effects can also result from the other antiviral medicine used together with daclatasvir.

Contact your healthcare professional if side effects are persistent, severe or concerning.

Important Hepatitis B Warning

Patients being considered for direct-acting antiviral treatment for hepatitis C should be evaluated for hepatitis B virus (HBV) infection before treatment.

HBV reactivation can occur in patients with current or previous hepatitis B infection receiving HCV direct-acting antiviral therapy and can result in serious liver problems. The product information for daclatasvir-containing treatment specifically highlights this risk.

Your doctor may perform blood tests before and during treatment when appropriate.

Daclahep Drug Interactions

Daclatasvir can interact with other medicines, and these interactions can affect antiviral treatment.

Tell your doctor about all prescription medicines, OTC medicines, vitamins and herbal supplements you take.

Particular attention is required with medicines that affect drug-metabolizing enzymes and transport systems.

Certain strong enzyme inducers can significantly reduce daclatasvir concentrations and may make treatment less effective.

Do not start or stop another medicine while taking Daclahep without discussing it with your healthcare professional.

Daclatasvir and Amiodarone

If daclatasvir is used with certain other HCV antiviral medicines, important interactions can occur.

In particular, some sofosbuvir-containing combinations have been associated with serious symptomatic bradycardia when used with amiodarone.

Tell your doctor if you take amiodarone or another medicine for an abnormal heart rhythm before starting hepatitis C treatment.

Daclahep and Pregnancy

If you are pregnant, planning to become pregnant or breastfeeding, discuss your complete HCV treatment regimen with your doctor.

Pregnancy considerations depend on the entire combination of medicines used to treat hepatitis C rather than daclatasvir alone.

Do not start or stop hepatitis C treatment because of pregnancy without medical advice.

Daclahep for USA, UK and Australia

Customers searching for Daclahep 60mg USA, Daclahep 60mg UK, Daclahep 60mg Australia, Daclatasvir 60mg or generic Daclatasvir should be aware that brand names, approved indications, availability and prescribing requirements differ between countries.

In Australia, the TGA has published an assessment of daclatasvir/dihydrochloride products and identifies daclatasvir products as prescription medicines.

The Australian TGA also advises consumers and businesses to check the Australian Register of Therapeutic Goods (ARTG) for products legally supplied in Australia.

For the USA, UK and Australia, customers should verify the applicable local regulatory and prescription requirements before obtaining or using this medicine.

Frequently Asked Questions

What is Daclahep 60mg Tablet?

Daclahep 60mg Tablet contains daclatasvir 60mg, a direct-acting antiviral used in combination with other medicines for chronic hepatitis C treatment.

What is the active ingredient in Daclahep?

The active ingredient is daclatasvir, supplied as daclatasvir dihydrochloride.

What is Daclatasvir 60mg used for?

Daclatasvir 60mg is used as part of combination antiviral therapy for chronic hepatitis C virus infection.

Is Daclatasvir an antiviral?

Yes. Daclatasvir is a direct-acting antiviral (DAA) that targets the HCV NS5A protein.

Can Daclahep be taken alone?

No. Daclatasvir is used as part of a combination hepatitis C treatment regimen. Your healthcare professional will determine which antiviral medicines should be used with it.

Can Daclahep be taken with food?

Daclatasvir tablets may generally be taken with or without food, according to the product information. Follow the instructions supplied with your specific medicine.

What happens if I miss a dose?

Follow the missed-dose instructions provided with your product and contact your healthcare professional if you are unsure. Do not take a double dose unless specifically instructed.

Does Daclahep cure hepatitis C?

Daclatasvir is part of antiviral treatment designed to eliminate HCV. Whether treatment successfully clears the virus depends on the complete treatment regimen and individual patient factors. Your doctor will monitor your response to treatment.

Can Daclahep be used for hepatitis B?

No. Daclahep/daclatasvir is an HCV antiviral and is used for hepatitis C treatment. Patients should nevertheless be screened for hepatitis B before starting HCV direct-acting antiviral therapy because HBV reactivation can occur.

Storage

Store Daclahep according to the manufacturer’s instructions on the product packaging.

Keep the medicine:

• In its original packaging where appropriate
• Protected from excessive moisture
• Away from excessive heat
• Out of reach of children
• Within the stated expiry date

Some daclatasvir product information specifies storage at temperatures not exceeding 30°C and protection from moisture. Always follow the instructions supplied with your particular product.

Important Safety Information

Daclahep 60mg is a prescription antiviral medicine. It should be used only under the supervision of a qualified healthcare professional experienced in hepatitis C treatment.

Daclatasvir should be used with the appropriate companion antiviral medicine. Drug interactions can be clinically important, and patients should disclose all medicines and supplements before treatment.

Patients with current or previous hepatitis B infection should be evaluated before starting HCV direct-acting antiviral therapy because HBV reactivation can cause serious liver complications.

Product availability, formulation, approved indications, packaging and prescription requirements may vary between the USA, UK and Australia.